Quality along the Supply Chain – KIT Spinoff simQoo Develops Quality Management Software for Companies with a Global Network of Suppliers

Team des KIT-wbk Start-Ups “simQoo” mit Mentorin Fr. Prof. Lanza

When companies are forced to recall their products due to faulty brakes or hazardous substances in food, it becomes clear that quality deficiencies may be associated with high risks for the consumer and high financial losses for the manufacturer. Professional quality management (PQM) is indispensable for manufacturers. However, the process of controlling the goods is of increasing complexity, the more suppliers are involved.

“Quality deficiencies frequently creep into the supply chain. An end product without quality deficiencies requires seamless integration of all suppliers into the quality management scheme,” Kyle Kippenbrock and Stefan Stockey, the two founders of the KIT spinoff simQoo, say. The mechanical engineers are research assistants at the KIT Institute of Production Science (wbk). Their work on projects with German companies in China gave rise to the idea of establishing simQoo.

Quality management and the corresponding IT solutions cause many companies quite a headache: QM information is sent by e-mail, every supplier uses his own data format, statistical evaluation requires quite an effort. The software solutions applied at large enterprises are often associated with high investment costs and quickly outdated. Operation has to be learnt through time-consuming training. Often, it is carried out by a small group of QM experts only.

The solution developed by simQoo facilitates communication even beyond borders of companies. Via an easy-to-understand user interface, all parties involved in the production process can make their QM data accessible to partner enterprises. The data are made available in a standardized format. Error messages or complaints are transmitted in real time. Manufacturers and suppliers can respond quickly to potential quality deficiencies. Stefan Stockey uses a tax declaration software to explain the concept: “You do not need to be a tax expert and to know all currently valid regulations in order to operate the software. In the same way, the software solution of simQoo guides the user step by step through the QM process.” The software can be operated with a PC or smartphone from everywhere in the world. The only thing that is needed is access to the internet.

Their mentor, Professor Dr.-Ing. Gisela Lanza from the Institute of Production Science (wbk), and spinoff coach Dr. Rolf Blattner from KIT’s Innovation Management Service Unit supported the young entrepreneurs actively from the very beginning. Since January 2013, simQoo has been granted an “Exist” founders grant.

Kyle Kippenbrock and Stefan Stockey are now looking for clients to carry out pilot projects. Within the framework of these projects, the software is to be further developed and tested in practice. The clients will profit from a more efficient quality management  and from an increase in competitiveness.

Contact
Dipl.-Ing. Stefan Stockey
Kaiserstr. 12, D-76131 Karlsruhe, Germany
Phone:  +49 (0) 721 608-44185+49 (0) 721 608-44185
Mobile : +49 (0) 160 962-54940+49 (0) 160 962-54940
stefan.stockey@simQoo.com
www.simQoo.com

Gene Transfer of the Next Generation – KIT Spin-off Incella GmbH Has Developed a New Method to Optimize Gene Transfer in Cells for the Development of New Cell Transfectants

Die KIT-Wissenschaftler und Gründer des Spin-offs Incella Dr. Pavel Levkin und Dr. Gary Davidson

Genome research and microbiological diagnosis are major components of biomedical examinations. In pharmaceutical industry, such screenings of cell cultures are made to understand the functions of genes or to produce antibodies against certain diseases in a cell. A method frequently applied for fundamental research into cell biology is cell transfection. Foreign DNA or RNA molecules are introduced into a cell, thus causing a genetic modification. Lipid-similar molecules are applied most often for cell transfection.

Continue reading

The FlexConveyor: KIT spin-off flexlog GmbH develops a modular construction system which can replace rigid conveying systems

2013_1 flexlog Bild

To manufacture and distribute products, many flows of goods have to be constantly commissioned in complex conveying systems. Common material goods flow systems usually consist of rigidly defined roller conveyor sections with central control, which are integrated into a manufacturing plant in a fixed fashion: when the flow of goods increases, a change of conveying route is necessarily linked to a high effort in time and costs.

Continue reading

High content screening from a single source – KIT spin-off ACQUIFER AG offers a platform for image based life science research

Dr. Urban Liebel und Thomas Schurr

To study complex biomedical questions extensive screening experiments are necessary. In the research of widespread diseases, such as cancer or Alzheimer’s, a very high number of samples are studied under fully automated microscopes. However, on a global scale hardly any laboratories have the complete equipment and resources of interdisciplinary employees which are necessary for this. Biological methods, robot supported laboratory automation, intelligent microscopes, very large amounts of data, automatic image evaluation, and secure data exchange with other laboratories are always individual challenges. ACQUIFER AG offers a cost efficient overall solution for this.

Continue reading

Award winning cancer research – KIT spin-off amcure GmbH convinces at the CyberOne Award with a new approach for the pancreatic cancer therapy

amcure-Gründer Dr. Matthias Klaften und Dr, Alexandra Matzke

The amcure GmbH in Karlsruhe was awarded with the second place of the Cyber One Award on June 12th, 2012 for its new active substance against pancreatic cancer. Furthermore, the amcure GmbH was awarded the renowned special prize of the state of Baden-Württemberg. The four company founders of the young spin-off of the Karlsruhe Institute of Technology work on the active substance AM001, which could open up new possibilities of treating cancer of the pancreas in the future.

Continue reading

1 2 3 4